EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S ‐Palmitoylated IRHOM2

Minxuan Xu iD, Jun Tan, Liancai Zhu, Chenxu Ge, Yi Zhang, Fufeng Gao, Xianling Dai, Qin Kuang, Jie Chai, Benkui Zou, Bochu Wang

Advanced Science · 2023-10 · 10 (28)

DOI: 10.1002/advs.202302130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.08.2023. Verfasst von Minxuan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing Univer…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Research Program of Basic Research and Frontier Technology, Science and Technology Research Program of Chongqing Education Commission of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Underestimation of the complexity of pathogenesis in nonalcoholic steatohepatitis (NASH) significantly encumbers development of new drugs and targeted therapy strategies. Inactive rhomboid protein 2 (IRHOM2) has a multifunctional role in regulating inflammation, cell survival, and immunoreaction. Although cytokines and chemokines promote IRHOM2 trafficking or cooperate with partner factors by phosphorylation or ubiquitin ligases‐mediated ubiquitination to perform physiological process, it remains unknown whether other regulators induce IRHOM2 activation via different mechanisms in NASH progression. Here the authors find that IRHOM2 is post‐translationally S ‐palmitoylated at C476 in iRhom homology domain (IRHD), which facilitates its cytomembrane translocation and stabilization. Fatty‐acids challenge can directly promote IRHOM2 trafficking by increasing its palmitoylation. Additionally, the authors identify Zinc finger DHHC‐type palmitoyltransferase 3 (ZDHHC3) as a key acetyltransferase required for the IRHOM2 palmitoylation. Fatty‐acids administration enhances IRHOM2 palmitoylation by increasing the direct association between ZDHHC3 and IRHOM2, which is catalyzed by the DHHC (C157) domain of ZDHHC3. Meanwhile, a metabolic stresses‐triggered increase of ZDHHC3 maintains palmitoylated IRHOM2 accumulation by blocking its ubiquitination, consequently suppressing its ubiquitin‐proteasome‐related degradation mediated by tripartite motif containing 31 (TRIM31). High‐levels of ZDHHC3 protein abundance positively correlate with the severity of NASH phenotype in patient samples. Hepatocyte‐specific dysfunction of ZDHHC3 significantly inhibits palmitoylated IRHOM2 deposition, therefore suppressing the fatty‐acids‐mediated hepatosteatosis and inflammation in vitro, as well as NASH pathological phenotype induced by two different high‐energy diets (HFHC & WTDF) in the in vivo rodent and rabbit model. Inversely, specific restoration of ZDHHC3 in hepatocytes markedly provides acceleration over the course of NASH development via increasing palmitoylation of IRHOM2 along with suppression of ubiquitin degradation. The current work uncovers that ZDHHC3‐induced palmitoylation is a novel regulatory mechanism and signal that regulates IRHOM2 trafficking, which confers evidence associating the regulation of palmitoylation with NASH progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsHumansRabbitsLipoylationInflammationPhosphorylationFatty AcidsUbiquitinsTripartite Motif ProteinsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

Palmitoylationhepatosteatosisinactive rhomboid protein 2 (IRHOM2)nonalcoholic steatohepatitis (NASH)tripartite motif containing 31 (TRIM31)zinc finger DHHC-type palmitoyltransferase 3 (ZDHHC3)

Substanzen

Fatty AcidsUbiquitinsTRIM31 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, 400067, P. R. China.
  • College of Modern Health Industry, Chongqing University of Education, Chongqing, 400067, P. R. China.
  • Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400030, P. R. China.
  • Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University&Shandong Academy of Medical Science, Jinan, 250117, P. R. China.

ORCID-Profile: Minxuan Xu

Förderung

  • National Natural Science Foundation of China
  • Chongqing Research Program of Basic Research and Frontier Technology
  • Science and Technology Research Program of Chongqing Education Commission of China
  • Natural Science Foundation of Chongqing, China
  • Chongqing Professional Talents Plan for Innovation and Entrepreneurship Demonstration Team

Zitieren

APA

Xu, M., Tan, J., Zhu, L., Ge, C., Zhang, Y., Gao, F., Dai, X., Kuang, Q., Chai, J., Zou, B., & Wang, B. (2023). Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S ‐Palmitoylated IRHOM2. Advanced Science, 10(28). https://doi.org/10.1002/advs.202302130

Vancouver

Xu M, Tan J, Zhu L, Ge C, Zhang Y, Gao F, et al. Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S ‐Palmitoylated IRHOM2. Advanced Science. 2023;10(28). doi:10.1002/advs.202302130

BibTeX
@article{Xu2023,
  author = {Xu, Minxuan and Tan, Jun and Zhu, Liancai and Ge, Chenxu and Zhang, Yi and Gao, Fufeng and Dai, Xianling and Kuang, Qin and Chai, Jie and Zou, Benkui and Wang, Bochu},
  title = {Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S ‐Palmitoylated IRHOM2},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {28},
  doi = {10.1002/advs.202302130}
}
Kostenlos starten →